Anticoagulation in AF following PCI: guideline updates and real-world evidence

PART 1: Managing AF following PCI: Interpreting ESC guideline updates

Learning objectives

  • Summarise the recent updates to the European Society of Cardiology Atrial Fibrillation guidelines
  • State the clinical studies that have influenced the recent guideline updates
  • Recall the different study designs used in pivotal clinical trials assessing NOAC use post-PCI

 


Programme Outline
  • PART 1: Managing AF following PCI: Interpreting ESC guideline updatesLeonardo De LucaJan Steffel
  • PART 2: Real world outcomes in AF patients undergoing PCILeonardo De LucaJan Steffel
This discussion was funded by an unrestricted educational service from Boehringer Ingelheim

PART 2: Real world outcomes in AF patients undergoing PCI